All In MedTech

Company

Inari Medical

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

Not publicly listed. It has raised money in private placements reported to the SEC on Form D (filings through 2026Q3). A company with no recent filing may since have been acquired.

Private

Latest round: equity, $27.0M raised of $27.0M sought, first sale Mar 29, 2018, 20 investors.

Funding rounds (Form D)

One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.

First saleTypeRaisedRound sizeInvestorsExemption and agentFiling
Mar 29, 2018Equity$27.0M$27.0M20Rule 506(b)Form D ↗Apr 2, 2018

3 more funding rounds with a free account

Company details

From the company's latest Form D.

Legal name
Inari Medical, Inc.
Headquarters
Irvine, California
Incorporated
Delaware over five years before filing
Entity type
Corporation
Revenue range
Decline to Disclose
Industry filed under
Other Health Care

Executives, directors and promoters

As listed on the latest Form D.

    7 more people on the filing with a free account

    Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

    Investors

    5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors from funding announcements and the firms' own portfolio pages.

    The investor database is free with an account

    For Inari Medical we have 2 venture investors.

    Sign up free with your name, company and ZIP code to see the 5%+ shareholders and government grant funders behind device companies.

    Latest FDA decisions

    The 8 newest of 58 since 2015.

    Search the Clearance Tracker

    57 more FDA decisions with a free account

    Device trials

    Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

    Open in the Trial Radar
    • NCT06394739 · 100 participants (planned) · Start Sep 9, 2024 · Primary completion Apr 2027

      Device: Thrombectomy · For: In-stent Thrombosis

      Sites: New Haven, Connecticut; Washington D.C., District of Columbia; Boise, Idaho · 17 sites in all

    12 more trials with a free account

    Adverse event reports received per month

    Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

    Search the MAUDE Monitor
    • Malfunction
    • Injury
    • Death
    • Other
    View as table
    MonthMalfunctionInjuryDeathOther
    Dec 230530
    Jan 240220
    Feb 240510
    Mar 240610
    Apr 242210
    May 243130
    Jun 242010
    Jul 244120
    Aug 242300
    Sep 240110
    Oct 241020
    Nov 242210
    Dec 245610
    Jan 252310
    Feb 257100
    Mar 254320
    Apr 253110
    May 254310
    Jun 252300
    Jul 255300
    Aug 254120
    Sep 251240
    Oct 2541000
    Nov 252810
    Dec 254421
    Jan 262300
    Feb 262610
    Mar 266900
    Apr 264400
    May 268100
    Jun 265200
    Jul 262300
    Aug 263500
    Sep 266310
    Oct 265430
    Nov 260000

    Device types named most often

    Last 12 months, by FDA product code. A company that sells more gets more reports.

    2 more in this ranking with a free account

    Brand names named most often

    Last 12 months, as written on the reports. One product can appear under several spellings.

    7 more in this ranking with a free account

    Recent recalls

    From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

    • Z-1728-2025 · Started Apr 8, 2025 · Posted by FDA May 6, 2025

      Reason given: Thrombectomy device specifies vessel range of 2.5-6 mm on the pouch, carton, and Instructions for Use rather than the correct vessel range of 3-6 mm, which could incrementally increase the radial force on the artery, which has the potential of vascular complications.

      Cause as FDA categorized it: Labeling Change Control · Device type: Peripheral Mechanical Thrombectomy With Aspiration (QEW)

    2 more recall records with a free account

    Back to all tools

    For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.